HP
30
-2
GM
82
2
CLX
50
4
SYF
83
-2
GE
61
-4
BMY
33
-2
LRCX
62
-2
BLK
58
-3
AIV
64
2
MAS
63
-5
MMM
40
5
DOV
79
-4
CMA
50
-5
CPB
49
2
AMZN
69
4
DLTR
51
7
SWK
62
-2
ZTS
65
2
FFIV
63
-3
EL
59
3
HP
30
-2
GM
82
2
CLX
50
4
SYF
83
-2
GE
61
-4
BMY
33
-2
LRCX
62
-2
BLK
58
-3
AIV
64
2
MAS
63
-5
MMM
40
5
DOV
79
-4
CMA
50
-5
CPB
49
2
AMZN
69
4
DLTR
51
7
SWK
62
-2
ZTS
65
2
FFIV
63
-3
EL
59
3
Financhill
Back

Relmada Therapeutics Vs. NeuroBo Pharmaceuticals Industry Stock Comparison

Sell
28

RLMD
Relmada Therapeutics

Last Price:
3.48
Seasonality Move:
-15.59%
Buy
53

NRBO
NeuroBo Pharmaceuticals

Last Price:
4.60
Seasonality Move:
-1.65%
Sell
28
Relmada Therapeutics (RLMD) is a Sell

Is Relmada Therapeutics a Buy, Sell or Hold?

  • The current Relmada Therapeutics [RLMD] share price is $3.49. The Score for RLMD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RLMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
NeuroBo Pharmaceuticals (NRBO) is a Buy

Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?

  • The current NeuroBo Pharmaceuticals [NRBO] share price is $4.60. The Score for NRBO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • NRBO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RLMD Stock Price Chart

What is Relmada Therapeutics's stock price today?

  • The Relmada Therapeutics share price today is $3.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.

NRBO Stock Price Chart

What is NeuroBo Pharmaceuticals's stock price today?

  • The NeuroBo Pharmaceuticals share price today is $4.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NRBO is experiencing buying pressure, which is a positive indicator for future bullish movement.

RLMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 35.31 Sell
Chaikin Money Flow: -14510 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.52 - 4.24) Sell
Bollinger Bands (100): (3.57 - 5.47) Sell

NRBO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 74.03 Buy
Chaikin Money Flow: 49085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.21 - 4.03) Buy
Bollinger Bands (100): (3.31 - 4.99) Buy

RLMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.64 Sell
20-day SMA: 3.72 Sell
50-day SMA: 4.47 Sell
200-day SMA: 3.75 Sell
8-day EMA: 3.6 Sell
20-day EMA: 3.81 Sell
50-day EMA: 4.21 Sell
200-day EMA: 4.37 Sell

NRBO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.1 Buy
20-day SMA: 3.66 Buy
50-day SMA: 3.97 Buy
200-day SMA: 3.99 Buy
8-day EMA: 4.13 Buy
20-day EMA: 3.89 Buy
50-day EMA: 3.96 Buy
200-day EMA: 8.37 Sell

Relmada Therapeutics Earnings Growth & RLMD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.26 per share.

NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Relmada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NeuroBo Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):